Novo and Hims resolve dispute, will sell obesity drugs together, Bloomberg News reports

Core Insights - Novo Nordisk plans to sell its weight-loss drug Wegovy on the Hims & Hers Health platform, ending a legal dispute between the two companies [1] Company Developments - Novo Nordisk and Hims & Hers Health are expected to announce a new partnership soon, potentially as early as Monday [1] - The resolution of the dispute allows both companies to collaborate on the distribution of obesity drugs, which may enhance market reach and sales [1]